Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dimethyl fumarate associated lymphopenia in clinical practice.
Comparison between balanced steady-state free precession and standard spoiled gradient echo magnetization transfer ratio imaging in multiple sclerosis: methodical and clinical considerations.
Visual pathway neurodegeneration winged by mitochondrial dysfunction.
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS.
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis.
Optic Neuritis and the Visual Pathway: Evaluation of Neuromyelitis Optica Spectrum by Resting-State fMRI and Diffusion Tensor MRI.
Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis.
Most Scottish neurologists do not apply the 2010 McDonald criteria when diagnosing multiple sclerosis.
Rituximab treatment did not aggravate ongoing progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosis.
Myelin damage and repair in pathologic CNS: challenges and prospects.
Reviewing the role of Resveratrol as a natural modulator of microglial activities.
Exercise and cognition in multiple sclerosis: The importance of acute exercise for developing better interventions.
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
Pathogenesis of Pediatric Multiple Sclerosis.
PET imaging of focal demyelination and remyelination in a rat model of multiple sclerosis: comparison of [(11)C]MeDAS, [ (11)C]CIC and [ (11)C]PIB.
Validity of the diagnostic criteria for chronic cerebrospinal venous insufficiency and association with multiple sclerosis.
The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
Are Natalizumab and Fingolimod Analogous Second-Line Options for the Treatment of Relapsing-Remitting Multiple Sclerosis? A Clinical Practice Observational Study.
Advances in the treatment of relapsing - Remitting multiple sclerosis.
Validating archetypes for the Multiple Sclerosis Functional Composite.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Predictors of the physical impact of Multiple Sclerosis following community-based, exercise trial.

Pages